EP0802787A4 - In situ gelbildender trägerstoff für die verabreichung von bioaktiven substanzen und verwendungsverfahren - Google Patents

In situ gelbildender trägerstoff für die verabreichung von bioaktiven substanzen und verwendungsverfahren

Info

Publication number
EP0802787A4
EP0802787A4 EP95921627A EP95921627A EP0802787A4 EP 0802787 A4 EP0802787 A4 EP 0802787A4 EP 95921627 A EP95921627 A EP 95921627A EP 95921627 A EP95921627 A EP 95921627A EP 0802787 A4 EP0802787 A4 EP 0802787A4
Authority
EP
European Patent Office
Prior art keywords
situ
administration
methods
bioactive substances
yellowing substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95921627A
Other languages
English (en)
French (fr)
Other versions
EP0802787A1 (de
Inventor
Kenneth J Himmelstein
Bert O Haglund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska Lincoln
University of Nebraska System
Original Assignee
University of Nebraska Lincoln
University of Nebraska System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska Lincoln, University of Nebraska System filed Critical University of Nebraska Lincoln
Publication of EP0802787A1 publication Critical patent/EP0802787A1/de
Publication of EP0802787A4 publication Critical patent/EP0802787A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
EP95921627A 1994-06-17 1995-06-09 In situ gelbildender trägerstoff für die verabreichung von bioaktiven substanzen und verwendungsverfahren Withdrawn EP0802787A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26173194A 1994-06-17 1994-06-17
US261731 1994-06-17
PCT/US1995/007333 WO1995035093A1 (en) 1994-06-17 1995-06-09 In situ gel-forming delivery vehicle for bio-affecting substances, and method of use

Publications (2)

Publication Number Publication Date
EP0802787A1 EP0802787A1 (de) 1997-10-29
EP0802787A4 true EP0802787A4 (de) 1998-09-02

Family

ID=22994617

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95921627A Withdrawn EP0802787A4 (de) 1994-06-17 1995-06-09 In situ gelbildender trägerstoff für die verabreichung von bioaktiven substanzen und verwendungsverfahren

Country Status (5)

Country Link
EP (1) EP0802787A4 (de)
JP (1) JPH10501814A (de)
AU (1) AU2638795A (de)
CA (1) CA2192708A1 (de)
WO (1) WO1995035093A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737406B1 (fr) † 1995-08-04 1997-10-24 Sederma Sa Gel a activite physique pour produits cosmetiques
US20020064546A1 (en) 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
US6258351B1 (en) 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
DE19701912C1 (de) * 1997-01-10 1998-05-14 Jenapharm Gmbh Injizierbares Implantat
US6596291B2 (en) 1997-12-05 2003-07-22 Thomas A. Bell Compositions and methods for treating surfaces infected with ectoparasitic insects
AU769224B2 (en) * 1998-12-28 2004-01-22 Taisho Pharmaceutical Co., Ltd. External preparation
AU4977800A (en) * 1999-04-26 2000-11-10 California Institute Of Technology (in situ) forming hydrogels
US7173064B2 (en) 2001-07-09 2007-02-06 Repros Therapeutics Inc. Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
US7737185B2 (en) 2001-07-09 2010-06-15 Repros Therapeutics Inc. Methods and compositions with trans-clomiphene
AU2002318225B2 (en) 2001-07-09 2007-12-13 Repros Therapeutics Inc. Methods and materials for the treatment of testosterone deficiency in men
SE0302509D0 (sv) 2003-09-19 2003-09-19 Amersham Biosciences Ab Matrix for separation of polyethers and method of separation
NZ556499A (en) 2005-02-04 2011-02-25 Repros Therapeutics Inc Methods and materials with trans-clomiphene for the treatment of male infertility
BRPI0609389A2 (pt) 2005-03-22 2010-03-30 Repros Therapeutics Inc tablete, composição e respectivos usos
BRPI0818637A2 (pt) 2007-10-16 2015-04-07 Repros Therapeutics Inc Métodos de tratamento de sintoma da síndrome metabólica, de glicose em jejum prejudicada, da síndrome metabólica e de redução de níveis de glicose em, jejum em sujeito com hipogonadismo hipogonadotrófico secundário ou idiopático
RU2439090C1 (ru) * 2010-08-09 2012-01-10 Федеральное государственное унитарное предприятие "Научно-исследовательский институт химии и технологии полимеров имени академика В.А. Каргина с опытным заводом" (ФГУП "НИИ полимеров") Способ получения интерполимерного комплекса
UA113291C2 (xx) 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
HK1216502A1 (zh) 2012-11-02 2016-11-18 Repros Therapeutics Inc. 用於癌症治療的反式-克羅米芬
WO2016170531A1 (en) * 2015-04-20 2016-10-27 Botanocap Ltd. Liquid and solid core microcapsules formed by interpolymeric complexation
WO2020033677A1 (en) 2018-08-08 2020-02-13 Johnson Lanny Leo Methods of diagnosing and treating infected implants

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9535093A1 *

Also Published As

Publication number Publication date
WO1995035093A1 (en) 1995-12-28
CA2192708A1 (en) 1995-12-28
JPH10501814A (ja) 1998-02-17
AU2638795A (en) 1996-01-15
EP0802787A1 (de) 1997-10-29

Similar Documents

Publication Publication Date Title
EP0802787A4 (de) In situ gelbildender trägerstoff für die verabreichung von bioaktiven substanzen und verwendungsverfahren
DE69524402D1 (de) Arzneiabgabevorrichtung und deren konstruktionsmethode
DE69033199D1 (de) Mittel zur feuchthaltung von gewebe und verfahren
DE69732225D1 (de) Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
DE69527988D1 (de) Einrichtung und Verfahren für die Ablieferung von Chipkomponenten
DE60032940D1 (de) Neue verfahren und zubereitungen die opioiden und deren antagonisten enthalten
EP0790826A4 (de) Dyhydropyrimidine und deren verwendungen
DE69028341D1 (de) Absorbierende Produkte und deren Herstellung
FI970771L (fi) Uusia allergisten sairauksien hoidossa käyttökelpoisia substituoituja piperidiinejä
DE69007886D1 (de) Östradiol enthaltende Mittel und Verfahren zur topischen Anwendung.
FI963215A7 (fi) Laite ja menetelmä ristiselän alueen jatkuvaa passiivista liikettä varten
DE69331339D1 (de) Gerät und verfahren zur bestimmung der blutgerinnungszeit
EP1027016A4 (de) Verfahren und pharmazeutische zusammensetzungen zum verschluss von metzhautrissen
DE69025386D1 (de) Polymethylalkylsiloxanemulsionen und Verfahren
BR9506119A (pt) Composição farmacêutica e forma de dosagem farmacêutica unitária
DE69507650D1 (de) Herstellungsverfahren und Zusammensetzung von Stoffen für Quecksilberfreisetzungsvorrichtung und damit hergestellte Vorrichtungen
FI963252L (fi) Kivun hoitoon tarkoitetut uudet opioidipeptidit ja niiden käyttö
DE69525998D1 (de) Herstellungsverfahren und Zusammensetzung von Stoffen für Quecksilberfreisetzungsvorrichtung und damit hergestellte Vorrichtungen
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE69304708D1 (de) Verfahren und vorrichtung für die zubereitung von mischungen mit komprimierten fluiden
DE69328118D1 (de) Verbesserter strangverdrängungstest und dafür verwendbarer komplex
ATE234180T1 (de) Vorrichtung zum herstellen und gleichzeitigem verteilen von zementmischungen oder dergleichen
DE69513803D1 (de) Alumoxanen und katalysatore die alumoxanen enthalten
DE4495520T1 (de) Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19980722

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19981009